68Ga-PSMA Uptake Patterns of Clear Cell Renal Carcinoma Across Different Histopathological Subtypes. (January 2022)

• Record Type: Journal Article
• Authors: Oflas, Melis; Ozluk, Yasemin; Sanli, Oner; Ozkan, Zeynep Gozde; Kuyumcu, Serkan
• Is Part Of: Clinical nuclear medicine. Volume 47:Number 1(2022)
• Publication Date: 2022-01
• Subjects: renal cell carcinoma -- 68Ga-PSMA -- PET/CT -- clear cell carcinoma -- Xp11 translocation; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000003814
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: 68 Ga–prostate-specific membrane antigen (PSMA) PET/CT is a well-established imaging modality in patients with prostate cancer; however, PSMA expression is also reported in the tumor-associated neovasculature, including but not limited to hepatocellular carcinoma, breast cancer, and renal cell carcinoma. Herein, we present 2 patients diagnosed with different histopathological subtypes of renal cell carcinoma who underwent 68 Ga-PSMA PET/CT before surgery. Both cases have different PSMA expression characteristics and are presented along with pathological findings.